Comments
Loading...

Cabaletta Bio Analyst Ratings

CABANASDAQ
Logo brought to you by Benzinga Data
$1.74
0.000.00%
At close: -
$1.71
-0.03-1.71%
After Hours: 7:37 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$50.00
Lowest Price Target1
$3.00
Consensus Price Target1
$22.38

Cabaletta Bio Analyst Ratings and Price Targets | NASDAQ:CABA | Benzinga

Cabaletta Bio Inc has a consensus price target of $22.38 based on the ratings of 13 analysts. The high is $50 issued by Cantor Fitzgerald on June 21, 2024. The low is $3 issued by Wells Fargo on April 1, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Citigroup, and Guggenheim on June 11, 2025, May 16, 2025, and May 16, 2025, respectively. With an average price target of $21 between HC Wainwright & Co., Citigroup, and Guggenheim, there's an implied 1127.85% upside for Cabaletta Bio Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jan
1
Feb
4
1
Apr
3
May
1
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Citigroup
Guggenheim
Wells Fargo
UBS

1calculated from analyst ratings

Analyst Ratings for Cabaletta Bio

Buy NowGet Alert
06/11/2025Buy Now1361.73%HC Wainwright & Co.
Douglas Tsao
$25 → $25ReiteratesBuy → BuyGet Alert
05/16/2025Buy Now660.1%Citigroup
Samantha Semenkow
$17 → $13MaintainsBuyGet Alert
05/16/2025Buy Now1361.73%Guggenheim
Yatin Suneja
$23 → $25MaintainsBuyGet Alert
05/15/2025Buy Now1361.73%Guggenheim
Yatin Suneja
$23 → $25MaintainsBuyGet Alert
04/01/2025Buy Now75.41%Wells Fargo
Derek Archila
$6 → $3MaintainsEqual-WeightGet Alert
04/01/2025Buy Now1244.79%Guggenheim
Yatin Suneja
$23 → $23ReiteratesBuy → BuyGet Alert
04/01/2025Buy Now309.28%UBS
Trung Huynh
$10 → $7MaintainsBuyGet Alert
04/01/2025Buy Now1186.32%Morgan Stanley
Michael Ulz
$30 → $22MaintainsOverweightGet Alert
04/01/2025Buy Now1361.73%HC Wainwright & Co.
Douglas Tsao
$25 → $25ReiteratesBuy → BuyGet Alert
02/18/2025Buy Now1361.73%HC Wainwright & Co.
Douglas Tsao
$25 → $25ReiteratesBuy → BuyGet Alert
01/17/2025Buy Now1361.73%HC Wainwright & Co.
Douglas Tsao
$25 → $25ReiteratesBuy → BuyGet Alert
12/20/2024Buy Now250.82%Evercore ISI Group
Gavin Clark-Gartner
$15 → $6DowngradeOutperform → In-LineGet Alert
12/19/2024Buy Now250.82%Wells Fargo
Derek Archila
$12 → $6DowngradeOverweight → Equal-WeightGet Alert
11/18/2024Buy Now1361.73%HC Wainwright & Co.
Douglas Tsao
$25 → $25ReiteratesBuy → BuyGet Alert
11/15/2024Buy Now601.63%Wells Fargo
Derek Archila
$20 → $12MaintainsOverweightGet Alert
11/15/2024Buy Now1361.73%HC Wainwright & Co.
Douglas Tsao
$25 → $25ReiteratesBuy → BuyGet Alert
10/10/2024Buy Now484.69%UBS
Trung Huynh
→ $10Initiates → BuyGet Alert
09/17/2024Buy Now1361.73%HC Wainwright & Co.
Douglas Tsao
$25 → $25ReiteratesBuy → BuyGet Alert
08/12/2024Buy Now1069.39%Wells Fargo
Derek Archila
$35 → $20MaintainsOverweightGet Alert
08/12/2024Buy Now777.04%Evercore ISI Group
Gavin Clark-Gartner
$25 → $15MaintainsOutperformGet Alert
08/09/2024Buy Now1361.73%HC Wainwright & Co.
Douglas Tsao
$30 → $25MaintainsBuyGet Alert
06/21/2024Buy Now2823.46%Cantor Fitzgerald
Josh Schimmer
$50 → $50ReiteratesOverweight → OverweightGet Alert
06/17/2024Buy Now1771.02%Stifel
Ben Burnett
$32 → $32MaintainsBuyGet Alert
06/14/2024Buy Now1654.08%HC Wainwright & Co.
Douglas Tsao
$30 → $30ReiteratesBuy → BuyGet Alert
05/24/2024Buy Now1654.08%HC Wainwright & Co.
Douglas Tsao
$30 → $30ReiteratesBuy → BuyGet Alert
05/16/2024Buy Now1654.08%HC Wainwright & Co.
Douglas Tsao
$30 → $30ReiteratesBuy → BuyGet Alert
04/05/2024Buy Now2823.46%Cantor Fitzgerald
Joshua Schimmer
$50 → $50ReiteratesOverweight → OverweightGet Alert
04/04/2024Buy Now1654.08%Citigroup
Samantha Semenkow
$26 → $30MaintainsBuyGet Alert
03/22/2024Buy Now2823.46%Cantor Fitzgerald
Joshua Schimmer
$50 → $50ReiteratesOverweight → OverweightGet Alert
03/22/2024Buy Now1946.42%Wells Fargo
Derek Archila
$34 → $35MaintainsOverweightGet Alert
03/22/2024Buy Now1654.08%HC Wainwright & Co.
Douglas Tsao
$25 → $30MaintainsBuyGet Alert
03/21/2024Buy Now1771.02%Stifel
Ben Burnett
$31 → $32MaintainsBuyGet Alert
02/05/2024Buy Now2004.89%Jefferies
Kelly Shi
→ $36Initiates → BuyGet Alert
11/29/2023Buy Now1361.73%Morgan Stanley
Michael Ulz
$28 → $25MaintainsOverweightGet Alert
11/29/2023Buy Now1361.73%HC Wainwright & Co.
Douglas Tsao
→ $25ReiteratesBuy → BuyGet Alert
11/15/2023Buy Now2823.46%Cantor Fitzgerald
Joshua Schimmer
$40 → $50MaintainsOverweightGet Alert
11/10/2023Buy Now1887.96%Wells Fargo
Derek Archila
$39 → $34MaintainsOverweightGet Alert
11/10/2023Buy Now1361.73%HC Wainwright & Co.
Douglas Tsao
$17 → $25MaintainsBuyGet Alert
11/08/2023Buy Now1537.14%Morgan Stanley
Michael Ulz
$16 → $28MaintainsOverweightGet Alert
10/24/2023Buy Now2238.77%Cantor Fitzgerald
Joshua Schimmer
→ $40Initiates → OverweightGet Alert
10/19/2023Buy Now1712.55%Stifel
Ben Burnett
→ $31Initiates → BuyGet Alert
10/04/2023Buy Now893.98%HC Wainwright & Co.
Douglas Tsao
→ $17ReiteratesBuy → BuyGet Alert
09/18/2023Buy Now2180.3%Wells Fargo
Derek Archila
$14 → $39MaintainsOverweightGet Alert
09/05/2023Buy Now1186.32%Citigroup
Samantha Semenkow
→ $22Initiates → BuyGet Alert
08/14/2023Buy Now1887.96%Guggenheim
Yatin Suneja
→ $34ReiteratesBuy → BuyGet Alert
08/11/2023Buy Now893.98%HC Wainwright & Co.
Douglas Tsao
$15 → $17MaintainsBuyGet Alert
07/18/2023Buy Now1887.96%Guggenheim
Yatin Suneja
→ $34Initiates → BuyGet Alert
05/17/2023Buy Now777.04%HC Wainwright & Co.
Douglas Tsao
→ $15ReiteratesBuy → BuyGet Alert
05/12/2023Buy Now777.04%HC Wainwright & Co.
Douglas Tsao
→ $15ReiteratesBuy → BuyGet Alert
05/03/2023Buy Now777.04%HC Wainwright & Co.
Douglas Tsao
→ $15Reiterates → BuyGet Alert
04/10/2023Buy Now777.04%HC Wainwright & Co.
Douglas Tsao
→ $15Reiterates → BuyGet Alert
04/03/2023Buy Now777.04%HC Wainwright & Co.
Douglas Tsao
→ $15Reiterates → BuyGet Alert
03/22/2023Buy Now601.63%Chardan Capital
Geulah Livshits
→ $12Reiterates → BuyGet Alert
03/17/2023Buy Now484.69%Mizuho
Uy Ear
→ $10Reiterates → BuyGet Alert
03/17/2023Buy Now777.04%HC Wainwright & Co.
Douglas Tsao
$11 → $15MaintainsBuyGet Alert
02/17/2023Buy Now543.16%HC Wainwright & Co.
Douglas Tsao
→ $11Reiterates → BuyGet Alert
01/27/2023Buy Now835.51%Morgan Stanley
Michael Ulz
→ $16UpgradeEqual-Weight → OverweightGet Alert
01/03/2023Buy Now718.57%Wells Fargo
Derek Archila
$4 → $14MaintainsOverweightGet Alert
11/11/2022Buy Now601.63%Chardan Capital
Geulah Livshits
$13 → $12MaintainsBuyGet Alert
09/14/2022Buy Now133.88%Wells Fargo
Derek Archila
$14 → $4MaintainsOverweightGet Alert
08/30/2022Buy Now75.41%Morgan Stanley
Michael Ulz
$15 → $3DowngradeOverweight → Equal-WeightGet Alert
08/12/2022Buy Now660.1%Chardan Capital
Geulah Livshits
$17 → $13MaintainsBuyGet Alert

FAQ

Q

What is the target price for Cabaletta Bio (CABA) stock?

A

The latest price target for Cabaletta Bio (NASDAQ:CABA) was reported by HC Wainwright & Co. on June 11, 2025. The analyst firm set a price target for $25.00 expecting CABA to rise to within 12 months (a possible 1361.73% upside). 21 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cabaletta Bio (CABA)?

A

The latest analyst rating for Cabaletta Bio (NASDAQ:CABA) was provided by HC Wainwright & Co., and Cabaletta Bio reiterated their buy rating.

Q

When was the last upgrade for Cabaletta Bio (CABA)?

A

The last upgrade for Cabaletta Bio Inc happened on January 27, 2023 when Morgan Stanley raised their price target to $16. Morgan Stanley previously had an equal-weight for Cabaletta Bio Inc.

Q

When was the last downgrade for Cabaletta Bio (CABA)?

A

The last downgrade for Cabaletta Bio Inc happened on December 20, 2024 when Evercore ISI Group changed their price target from $15 to $6 for Cabaletta Bio Inc.

Q

When is the next analyst rating going to be posted or updated for Cabaletta Bio (CABA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cabaletta Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cabaletta Bio was filed on June 11, 2025 so you should expect the next rating to be made available sometime around June 11, 2026.

Q

Is the Analyst Rating Cabaletta Bio (CABA) correct?

A

While ratings are subjective and will change, the latest Cabaletta Bio (CABA) rating was a reiterated with a price target of $25.00 to $25.00. The current price Cabaletta Bio (CABA) is trading at is $1.71, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch